# Biomarin Pharmaceutical Inc: Form 8-K, filed Sep 1, 2026

- Company: [Biomarin Pharmaceutical Inc](/companies/bmrn.md) (CIK 1048477)
- Form: 8-K
- Filed: 2026-09-01
- Accepted by EDGAR: Sep 1, 2026, 09:23 ET
- Period: 2026-08-31
- Accession: 0001193125-26-377696
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1048477/000119312526377696/d110660d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1048477/000119312526377696/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1048477/000119312526377696/d110660d8k.htm

Filed Sep 1, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-377696. Last ingested by Listed: Nov 4, 2026, 16:43 ET. No prices; not investment advice.